Two acoustics from Cort’s China-based workshop that couldn’t be further apart in style, from the traditional overtones of the ...

Cort has expanded its G Series of affordable electric guitars with the G250 SE, an HSS bolt-on S-style that offers a heap of ...

Corcept Therapeutics Incorporated (CORT) stock saw a modest uptick, ending the day at $45.43 which represents a slight increase of $0.39 or 0.87% from the prior close of $45.04. The stock opened at ...

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...

The guitars, which have solid torrefied Sitka spruce top with layered sapele back and sides, are compact in size and are suited for all skill levels, according to the company. “As a ballplayer ...

Corcept (CORT) is at a 52-week high, but can investors hope for more gains in the future? We take a look at the company's fundamentals for clues. Corcept (CORT) shares have started gaining and ...

CORT). The firm highlighted the company's solid performance as the third quarter comes to a close and the fourth quarter approaches. Corcept's stock has seen a significant increase this year, with a ...

In another article, we discussed Corcept Therapeutics Incorporated (NASDAQ:CORT) and shared ClearBridge Small Cap Value Strategy’s views on the company in the previous quarter. In addition ...

On Monday, Corcept Therapeutics Incorporated (CORT) stock saw a modest uptick, ending the day at $46.28 which represents a slight increase of $2.35 or 5.35% from the prior close of $43.93. The stock ...

In a report released today, Joon Lee from Truist Financial maintained a Buy rating on Corcept Therapeutics (CORT – Research Report), with ...

Vandana Singh Corcept Moves 6.5% Higher: Will This Strength Last? Corcept Therapeutics (NASDAQ: CORT) shares soared 6.5% in the last trading session to close at $42.27. The move was backed by ...

Corcept Therapeutics, Inc. is a commercial-stage pharmaceutical company. It engages in the business of discovering and developing pharmaceutical products and medications to treat severe ...